We are live on ! Find out more
OPTN

OptiNose

Delisted

OPTN was delisted on the 20th of May, 2025.

49 hedge funds and large institutions have $62.2M invested in OptiNose in 2021 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 11 increasing their positions, 22 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.24% less ownership

Funds ownership: 2.85%2.61% (-0.24%)

11% less capital invested

Capital invested by funds: $70.2M → $62.2M (-$8M)

23% less funds holding

Funds holding: 6449 (-15)

50% less repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 22

74% less first-time investments, than exits

New positions opened: 5 | Existing positions closed: 19

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $1K

Holders
49
Holders Change
-15
Holders Change %
-23.44%
% of All Funds
0.86%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
5
Increased
11
Reduced
22
Closed
19
Calls
Puts
$1K
Net Calls
-$1K
Net Calls Change
-$1K

OPTN Hedge Fund Activity: Q3 2021 in Review

49 of the 5,713 institutional investors tracked by Wall St. Rank reported a position in OptiNose (OPTN) for Q3 2021, worth a combined $62.2M — down 11% from $70.2M a quarter earlier.

Sellers outnumbered buyers: 19 funds closed out of OPTN and 5 opened new positions — a net loss of 14 holders — while 22 trimmed existing stakes and 11 added.

The largest buyer was Easterly Investment Partners, opening a new position worth an estimated $960K. The largest seller was Wasatch Advisors, exiting entirely with an estimated $2.4M sold.

  • 49 institutional investors held OptiNose (OPTN) as of Q3 2021, down from 64 in Q2 2021.
  • Funds reported $62.2M of OptiNose stock for Q3 2021, down 11% quarter-over-quarter.
  • 5 funds opened new OptiNose positions in Q3 2021 and 19 closed out, a net change of -14 holders.
  • The largest OptiNose buyer in Q3 2021 was Easterly Investment Partners, an estimated $960K added.
  • The largest OptiNose seller in Q3 2021 was Wasatch Advisors, an estimated $2.4M sold.

Based on aggregated 13F filings for Q3 2021.